# PeptidesDB

> Open-source, citation-dense, side-by-side comparable peptide research reference. Claims link to primary literature where available. MIT-licensed code and content.

## Project

- Site: https://peptidesdb.org
- Repository: https://github.com/peptidesdb/peptidesdb
- License: MIT
- API: https://peptidesdb.org/api/peptides
- Full corpus (markdown): https://peptidesdb.org/llms-full.txt
- Per-compound markdown: https://peptidesdb.org/p/<slug>/llms.txt

## Peptides

- [5-Amino-1MQ](https://peptidesdb.org/p/5-amino-1mq): NNMT Inhibitor (small molecule) · animal-strong evidence
- [ACE-031](https://peptidesdb.org/p/ace-031): Activin Receptor IIB Decoy · phase-2 evidence
- [Adamax](https://peptidesdb.org/p/adamax): ACTH(4-10) Analogue · animal-strong evidence
- [Adipotide](https://peptidesdb.org/p/adipotide): Pro-apoptotic Vascular-Targeting Peptide · animal-strong evidence
- [AHK-Cu](https://peptidesdb.org/p/ahk-cu): Tripeptide-Copper Complex · animal-mechanistic evidence
- [AOD-9604](https://peptidesdb.org/p/aod-9604): Lipolytic HGH C-terminal fragment · phase-2 evidence
- [ARA 290](https://peptidesdb.org/p/ara-290): EPO-Derived Peptide · phase-2 evidence
- [BPC-157](https://peptidesdb.org/p/bpc-157): Pentadecapeptide · phase-2 evidence
- [BPC-157 + TB-500 Blend](https://peptidesdb.org/p/bpc-157-tb-500-blend): Multi-peptide blend · theoretical evidence
- [Bronchogen](https://peptidesdb.org/p/bronchogen): Tetrapeptide Bioregulator · animal-strong evidence
- [Cagrilintide](https://peptidesdb.org/p/cagrilintide): Amylin Analogue · phase-3 evidence
- [Cardiogen](https://peptidesdb.org/p/cardiogen): Bioregulator Peptide · animal-mechanistic evidence
- [Cartalax](https://peptidesdb.org/p/cartalax): Bioregulator Peptide · animal-mechanistic evidence
- [Cerebrolysin](https://peptidesdb.org/p/cerebrolysin): Neurotrophic Peptide Preparation · phase-3 evidence
- [Chonluten](https://peptidesdb.org/p/chonluten): Bioregulatory Peptide · animal-mechanistic evidence
- [CJC-1295 (no DAC)](https://peptidesdb.org/p/cjc-1295): GHRH Analogue (modified GRF 1-29) · phase-1 evidence
- [Cortagen](https://peptidesdb.org/p/cortagen): Bioregulatory Tetrapeptide · animal-mechanistic evidence
- [Crystagen](https://peptidesdb.org/p/crystagen): Tetrapeptide Bioregulator · animal-mechanistic evidence
- [Dermorphin](https://peptidesdb.org/p/dermorphin): Opioid Peptide · animal-strong evidence
- [Dihexa](https://peptidesdb.org/p/dihexa): Angiotensin IV Analogue · animal-strong evidence
- [DSIP](https://peptidesdb.org/p/dsip): Nonapeptide · human-mechanistic evidence
- [Epitalon](https://peptidesdb.org/p/epitalon): Tetrapeptide bioregulator · human-mechanistic evidence
- [Follistatin-344](https://peptidesdb.org/p/follistatin-344): Myostatin Antagonist · human-mechanistic evidence
- [FOXO4-DRI](https://peptidesdb.org/p/foxo4): Senolytic Peptide · animal-strong evidence
- [GDF-8](https://peptidesdb.org/p/gdf-8): TGF-β Superfamily Myokine · animal-strong evidence
- [GHK-Cu](https://peptidesdb.org/p/ghk-cu): Copper-binding tripeptide · human-mechanistic evidence
- [GHRP-2](https://peptidesdb.org/p/ghrp-2): GHRP / Ghrelin Receptor Agonist · phase-2 evidence
- [GHRP-6](https://peptidesdb.org/p/ghrp-6): GHRP / Ghrelin Receptor Agonist · phase-1 evidence
- [Glow Blend](https://peptidesdb.org/p/glow-blend): Multi-peptide blend · theoretical evidence
- [GLP-1 (7-37)](https://peptidesdb.org/p/glp-1-7-37): Incretin Hormone · human-mechanistic evidence
- [Glutathione](https://peptidesdb.org/p/glutathione): Endogenous Tripeptide · human-mechanistic evidence
- [Gonadorelin](https://peptidesdb.org/p/gonadorelin): GnRH Analogue · fda-approved evidence
- [HCG](https://peptidesdb.org/p/hcg): Glycoprotein Hormone · fda-approved evidence
- [Hexarelin](https://peptidesdb.org/p/hexarelin): GHRP / Ghrelin Receptor Agonist · phase-1 evidence
- [HGH 191AA](https://peptidesdb.org/p/hgh-191aa): Recombinant Human Growth Hormone · fda-approved evidence
- [HGH Fragment 176-191](https://peptidesdb.org/p/hgh-fragment-176-191): GH Fragment · animal-strong evidence
- [Humanin](https://peptidesdb.org/p/humanin): Mitochondrial-Derived Peptide · animal-strong evidence
- [IGF-1 LR3](https://peptidesdb.org/p/igf-1lr3): IGF-1 Analogue · animal-strong evidence
- [IGF-DES](https://peptidesdb.org/p/igf-des): IGF-1 Analogue · animal-strong evidence
- [Ipamorelin](https://peptidesdb.org/p/ipamorelin): GHRP / Ghrelin Receptor Agonist · phase-1 evidence
- [Kisspeptin-10](https://peptidesdb.org/p/kisspeptin-10): Neuropeptide · phase-2 evidence
- [KLOW Blend](https://peptidesdb.org/p/klow-blend): Multi-peptide blend · theoretical evidence
- [KPV](https://peptidesdb.org/p/kpv): Tripeptide (Lys-Pro-Val) · animal-strong evidence
- [Liraglutide](https://peptidesdb.org/p/liraglutide): GLP-1 Receptor Agonist · fda-approved evidence
- [Livagen](https://peptidesdb.org/p/livagen): Khavinson Bioregulator · animal-strong evidence
- [LL-37](https://peptidesdb.org/p/ll-37): Antimicrobial Peptide · human-mechanistic evidence
- [Matrixyl](https://peptidesdb.org/p/matrixyl): Cosmeceutical Pentapeptide · animal-mechanistic evidence
- [Mazdutide](https://peptidesdb.org/p/mazdutide): GLP-1/Glucagon Dual Agonist · phase-3 evidence
- [Melanotan-II](https://peptidesdb.org/p/melanotan-2): α-MSH Analog (cyclic heptapeptide) · phase-1 evidence
- [MGF](https://peptidesdb.org/p/mgf): IGF-1 Splice Variant · animal-strong evidence
- [MK-677](https://peptidesdb.org/p/mk-677): Ghrelin Receptor Agonist · phase-2 evidence
- [MOTS-c](https://peptidesdb.org/p/mots-c): Mitochondrial-derived peptide · animal-strong evidence
- [MT-1](https://peptidesdb.org/p/mt-1): α-MSH Analogue · fda-approved evidence
- [N-Acetyl Epitalon Amidate](https://peptidesdb.org/p/n-acetyl-epitalon-amidate): Bioregulator Tetrapeptide · animal-strong evidence
- [Ovagen](https://peptidesdb.org/p/ovagen): Khavinson Bioregulator · theoretical evidence
- [Oxytocin](https://peptidesdb.org/p/oxytocin): Neuropeptide Hormone · fda-approved evidence
- [P21](https://peptidesdb.org/p/p21): CNTF-Derived Neuropeptide · animal-mechanistic evidence
- [Pancragen](https://peptidesdb.org/p/pancragen): Bioregulatory Tetrapeptide · animal-strong evidence
- [PE 22-28](https://peptidesdb.org/p/pe-22-28): TREK-1 Antagonist · animal-strong evidence
- [PEG-MGF](https://peptidesdb.org/p/peg-mgf): IGF-1 Splice Variant · animal-mechanistic evidence
- [Pinealon](https://peptidesdb.org/p/pinealon): Tetrapeptide bioregulator · human-mechanistic evidence
- [PNC-27](https://peptidesdb.org/p/pnc-27): Anticancer Peptide · animal-strong evidence
- [Prostamax](https://peptidesdb.org/p/prostamax): Khavinson Bioregulator · animal-mechanistic evidence
- [PT-141](https://peptidesdb.org/p/pt-141): Melanocortin-4 Receptor Agonist · fda-approved evidence
- [PTD-DBM](https://peptidesdb.org/p/ptd-dbm): Fusion Peptide · animal-strong evidence
- [Retatrutide](https://peptidesdb.org/p/retatrutide): GLP-1 / GIP / Glucagon Triple Agonist · phase-2 evidence
- [Selank](https://peptidesdb.org/p/selank): Heptapeptide bioregulator · human-mechanistic evidence
- [Semaglutide](https://peptidesdb.org/p/semaglutide): GLP-1 Receptor Agonist · fda-approved evidence
- [Semax](https://peptidesdb.org/p/semax): Heptapeptide ACTH(4-10) analog · human-mechanistic evidence
- [Sermorelin](https://peptidesdb.org/p/sermorelin): GHRH Analogue (1-29) · phase-3 evidence
- [SNAP-8](https://peptidesdb.org/p/snap-8): SNARE Inhibitor Peptide · human-mechanistic evidence
- [SS-31](https://peptidesdb.org/p/ss-31): Mitochondrial-targeted tetrapeptide · fda-approved evidence
- [Survodutide](https://peptidesdb.org/p/survodutide): GLP-1/Glucagon Dual Agonist · phase-3 evidence
- [TB-500](https://peptidesdb.org/p/tb-500): Actin-sequestering peptide · phase-2 evidence
- [Teriparatide](https://peptidesdb.org/p/teriparatide): PTH Fragment · fda-approved evidence
- [Tesamorelin](https://peptidesdb.org/p/tesamorelin): GHRH Analogue · fda-approved evidence
- [Tesofensine](https://peptidesdb.org/p/tesofensine): Triple monoamine reuptake inhibitor (small molecule) · phase-3 evidence
- [Testagen](https://peptidesdb.org/p/testagen): Bioregulator Peptide · animal-mechanistic evidence
- [Thymalin](https://peptidesdb.org/p/thymalin): Polypeptide complex (thymus-derived) · human-mechanistic evidence
- [Thymosin α-1](https://peptidesdb.org/p/thymosin-alpha-1): Synthetic 28-AA thymic peptide · phase-3 evidence
- [Tirzepatide](https://peptidesdb.org/p/tirzepatide): GIP / GLP-1 Dual Receptor Agonist · fda-approved evidence
- [Triptorelin](https://peptidesdb.org/p/triptorelin): GnRH Agonist · fda-approved evidence
- [Vesugen](https://peptidesdb.org/p/vesugen): Bioregulatory Tripeptide · animal-mechanistic evidence
- [Vilon](https://peptidesdb.org/p/vilon): Khavinson Bioregulator · animal-strong evidence
- [VIP](https://peptidesdb.org/p/vip): Neuropeptide · phase-3 evidence

## Comparison

Pairwise comparison views at /compare/<peptide-a>-vs-<peptide-b> for any two peptides above. Each page compares mechanism, evidence, and reference data side-by-side, where available.

## Disclaimer

PeptidesDB is a research and educational reference. It is NOT medical advice. Consult a licensed clinician before any decision affecting health.